Stock 002020 ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Jingxin Pharmaceutical Co., Ltd.

Equities

002020

CNE000001K73

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
11.41 CNY +0.44% Intraday chart for Zhejiang Jingxin Pharmaceutical Co., Ltd. +13.08% -10.30%
Apr. 23 Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 01 Zhejiang Jingxin Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7,379 6,637 8,188 9,948 10,952 9,824 - -
Enterprise Value (EV) 1 7,379 6,637 8,188 9,948 10,952 9,824 9,824 9,824
P/E ratio 14.7 x 10.1 x 12.7 x 16.7 x 17.7 x 14.5 x 11.7 x 10.2 x
Yield 3.26% 3.52% - - 2.36% 2.8% 1.58% 4.03%
Capitalization / Revenue 2.02 x 2.04 x - - 2.74 x 2.24 x 1.92 x 1.74 x
EV / Revenue 2.02 x 2.04 x - - 2.74 x 2.24 x 1.92 x 1.74 x
EV / EBITDA - - - - 11.8 x 7.69 x 7.57 x 5.7 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 2.11 x 1.79 x - - 1.99 x 1.65 x 1.47 x 1.37 x
Nbr of stocks (in thousands) 824,515 801,278 861,029 816,739 861,029 861,029 - -
Reference price 2 8.950 8.283 9.510 12.18 12.72 11.41 11.41 11.41
Announcement Date 2/26/20 2/26/21 2/25/22 2/27/23 3/29/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,647 3,260 - - 3,999 4,391 5,108 5,634
EBITDA 1 - - - - 931.4 1,278 1,297 1,724
EBIT 1 602.1 759.3 - - 714.1 778 961 1,104
Operating Margin 16.51% 23.29% - - 17.86% 17.72% 18.81% 19.6%
Earnings before Tax (EBT) 1 603.4 753 - - 708 775 959.2 1,100
Net income 1 520.4 653.5 614 646.4 618.9 675.9 840.6 977
Net margin 14.27% 20.04% - - 15.48% 15.39% 16.46% 17.34%
EPS 2 0.6075 0.8175 0.7500 0.7300 0.7200 0.7850 0.9750 1.120
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 0.2917 0.2917 - - 0.3000 0.3200 0.1800 0.4600
Announcement Date 2/26/20 2/26/21 2/25/22 2/27/23 3/29/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 14.4% 17.4% 14.2% - 11.7% 11.4% 12.6% 13.4%
ROA (Net income/ Total Assets) 9.78% 11.6% - - - 7.8% 8.65% 9.8%
Assets 1 5,322 5,649 - - - 8,665 9,718 9,969
Book Value Per Share 2 4.250 4.630 - - 6.400 6.900 7.750 8.340
Cash Flow per Share 2 0.6200 0.6100 - - 0.9200 1.050 1.160 1.520
Capex 1 335 332 - - - 375 375 375
Capex / Sales 9.19% 10.17% - - - 8.54% 7.34% 6.66%
Announcement Date 2/26/20 2/26/21 2/25/22 2/27/23 3/29/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Zhejiang Jingxin Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
11.41
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD. Stock Zhejiang Jingxin Pharmaceutical Co., Ltd.
-10.30% 1.36B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002020 Stock
  4. Financials Zhejiang Jingxin Pharmaceutical Co., Ltd.